You Hongjun, Zhao Qianqian, Dong Mengya
Department of Cardiovascular Medicine, Shaanxi Provincial People's Hospital, Xi'an, 710068, Shaanxi, People's Republic of China.
Department of Clinical Immunology, The First Affiliated Hospital, Air Force Military Medical University, Xi'an, 710032, Shaanxi, People's Republic of China.
Int J Gen Med. 2022 Mar 4;15:2479-2490. doi: 10.2147/IJGM.S354885. eCollection 2022.
Accumulating evidences disclose that COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has a marked effect on acute myocardial infarction (AMI). Nevertheless, the underlying pathophysiology correlation between the AMI and COVID-19 remains vague.
Bioinformatics analyses of the altered transcriptional profiling of peripheral blood mononuclear cells (PBMCs) in patients with AMI and COVID-19 were implemented, including identification of differentially expressed genes and common genes between AMI and COVID-19, protein-protein interactions, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses, TF-genes and miRNA coregulatory networks, to explore their biological functions and potential roles in the pathogenesis of COVID-19-related AMI.
Our bioinformatic analyses of gene expression profiling of PBMCs in patients with AMI and COVID-19 provide us with a unique view regarding underlying pathophysiology correlation between the two vital diseases.
越来越多的证据表明,由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)对急性心肌梗死(AMI)有显著影响。然而,AMI与COVID-19之间潜在的病理生理相关性仍不明确。
对AMI和COVID-19患者外周血单个核细胞(PBMC)转录谱改变进行生物信息学分析,包括鉴定AMI和COVID-19之间的差异表达基因和共同基因、蛋白质-蛋白质相互作用、基因本体论和京都基因与基因组百科全书通路分析、转录因子-基因和微小RNA共调控网络,以探索它们在COVID-19相关AMI发病机制中的生物学功能和潜在作用。
我们对AMI和COVID-19患者PBMC基因表达谱的生物信息学分析,为我们提供了关于这两种重大疾病潜在病理生理相关性的独特视角。